Ecopharmacovigilance monitors the environmental impact of pharmaceuticals post-release. It investigates how drugs enter ecosystems, their persistence, and potential effects on wildlife and ecosystems. By assessing ecological risks, it aims to mitigate harm and develop sustainable pharmaceutical practices. Ecopharmacovigilance emphasizes the importance of considering environmental consequences in drug development, usage, and disposal, ensuring a balance between human health and environmental protection in the pharmaceutical industry's activities.

  • Integrative pharmacological investigations

Related Conference of Ecopharmacovigilance

July 25-26, 2024

34th Annual European Pharma Congress

Frankfurt, Germany
August 06-07, 2024

27th World Congress on Nursing, Pharmacology and Healthcare

Aix-en-Provence, France
August 28-29, 2024

4th International Conference on Pharmaceutical Chemistry

Aix-en-Provence, France
September 11-12, 2024

9th International Conference on Future Pharma and Innovations

Amsterdam, Netherlands
September 25-26, 2024

4th World Congress on Rare Diseases & Orphan Drugs

Paris, France
October 31-01, 2024

37th World Congress on Pharmacology

Amsterdam, Netherlands
November 26-27, 2024

3rd World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland
November 26-27, 2024

3rd World Congress on Precision and Personalized Medicine

Zurich, Switzerland
November 28-29, 2024

39th World Congress on Pharmacology and Therapeutics

Paris, France
November 28-29, 2024

12th International Conference on Clinical Trials

Vancouver, Canada
December 05-06, 2024

17th World Drug Delivery Summit

Dubai, UAE
April 14-15, 2025

18th European Biosimilars Congress

Aix-en-Provence, France

Ecopharmacovigilance Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in